AtheroNova Report issue

For profit Phase 1
Founded: Irvine CA United States (2006)
Status: Defunct (2015)

Organization Overview

First Clinical Trial
2013
NCT01931241
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

AtheroNova CMO | AtheroNova Inc.

Active Ingredients

Drugs in Phase 1 Trials (1)

hyodeoxycholic acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypercholesterolemia (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1